If explanted, give date: not applicable, as the lens remains implanted.The device was not returned for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
It was reported that after the intraocular lens (iol) was implanted, the patient was doing well, but experiencing some mild to moderate corneal edema at the wound.The patient's uncorrected vision is 20/40 post operative day 2.Through follow-up it was learned that the cornea edema was first noted on the first post-operative day, (b)(6) 2022.The surgeon added prednisolone acetate 1% qid, tapering by one drop each week to the pred/moxi/brom used that was used (with the same instructions) in order to speed the resolution of corneal edema.The patient is finished with those drops now.The patient no longer has corneal edema but still has trace descemet's folds at the wound.The patient's best corrected vision is 20/25 with -0.25 +0.50 x 90.No further information was provided.
|